enVVeno cites Journal of Vascular Surgery study showing venous valve therapy saves more than $32,000 per patient over five years

enVVeno Medical highlighted a peer-reviewed health economic analysis published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders.

Results were already presented via publication, positioning venous valve replacement as both clinically beneficial and lower cost than conservative care.

The study projected more than $32,000 in per-patient healthcare savings over five years, supporting a reimbursement case for enVVeno’s enVVe system.

Management plans to apply forthcoming clinical data from the TAVVE pivotal trial to the published model to support coverage decisions.

The analysis estimated $5.9 billion in annual healthcare savings with broader adoption, underscoring a large commercial opportunity.